Publications
Publications for March 2018
Apps for immunization – Leveraging mobile devices to place the individual at the centre of care
K Wilson, KM Atkinson and J Westeinde
Human Vaccines & Immunotherapeutics , 2015, 11(10):2395-9Successful methodology for large-scale surveillance of severe events following influenza vaccination in Canada, 2011 and 2012
JA Bettinger, I Rouleau, MC Gariépy, WR Bowie, L Valiquette, OG Vanderkooi, JD Kellner, BL Coleman, SA McNeil, A McCarthy, G De Serres and on behalf of the Public Health Agency of Canada/Canadian Institutes for Health Research Influenza Research Network
Euro Surveill , 2015;20(29):pii=21189.Parents and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay Lac-St-Jean (Quebec)
E Dubé, D Gagnon, D Hamel, S Belley, H Gagné, N Boulianne, M Landry and J Bettinger
Can J Infect Dis Med Microbiol , 2015;26(3):163-167Meningococcal B vaccine acceptability: Results of a longitudinal study in Quebec (Canada)
E Dubé, D Gagnon, M Quakki, B Belley, H Gagné, N Boulianne, M Landry and JA Bettinger
Vaccine Reports , 2016;6:29-35An evaluation of the feasibility and usability of a proof of concept mobile app for adverse event reporting post influenza vaccination
K Wilson, K Atkinson, J Westeinde, K Bell, K Marty, D Fergusson, S Deeks, N Crowcroft and J Bettinger
Human Vaccines & Immunotherapeutics , 2016;12:1738-1748Assessing the risk of intussusception and rotavirus vaccine safety in Canada
Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM and Deeks SL
Hum Vaccin Immunother , 2017;13(3):703-710Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak T, McNeil SA, Langley JM, Halperin SA and Canadian Immunization Research Network
CMAJ , 2017; 189(24):E819-E827Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network
KA Top, M-N Billard, M-C Gariepy, I Rouleau, JM Pernica, A Pham-Huy, C Quach, D Tran, W Vaudry, S Dobson, FD Boucher, A Carignan, T Jadavji, A McConnell, SA McNeil, SA Halperin, G De Serres and Canadian Immunization Research Network’s (CIRN) Special Immunization Clinics Network investigators
CMAJ , 2016;35(12):e384-e391Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers
KA Top, A Pham-Huy, V Price, L Sung, D Tran, W Vaudry, SA Halperin, G De Serres and Canadian Immunization Research Network’s (CIRN) Special Immunization Clinics Network investigators
Hum Vaccin Immunother , 2016 Apr; 12(4): 931–936.Canadian paediatricians’ approaches to managing patients with adverse events following immunization: The role of the Special Immunization Clinic network
KA Top, J Zafack, G De Serres and SA Halperin
Paediatr Child Health , 2014;19(6):310-314.